• LAST PRICE
    15.1800
  • TODAY'S CHANGE (%)
    Trending Up0.9600 (6.7511%)
  • Bid / Lots
    0.0000/ 0
  • Ask / Lots
    20.0000/ 2
  • Open / Previous Close
    14.1700 / 14.2200
  • Day Range
    Low 14.0900
    High 15.4350
  • 52 Week Range
    Low 13.6800
    High 24.4700
  • Volume
    192,996
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 14.22
TimeVolumeERAS
09:32 ET41514.17
09:35 ET10014.09
09:37 ET20014.31
09:42 ET20014.33
09:46 ET10014.22
09:48 ET20014.27
09:50 ET10014.24
09:51 ET10014.28
09:53 ET30014.3
09:55 ET50014.315
10:00 ET22714.345
10:02 ET140014.295
10:04 ET90014.36
10:09 ET30014.24
10:11 ET252114.29
10:13 ET70014.287
10:15 ET290014.3
10:18 ET30014.3025
10:20 ET20014.295
10:22 ET422014.38
10:24 ET780014.35
10:26 ET110014.29
10:27 ET10014.265
10:31 ET50014.265
10:33 ET70014.265
10:36 ET110014.245
10:38 ET20014.25
10:40 ET70014.23
10:42 ET70014.32
10:44 ET90014.295
10:45 ET274914.275
10:47 ET165014.37
10:49 ET550014.42
10:51 ET20014.44
10:56 ET70014.295
10:58 ET166214.34
11:02 ET100014.35
11:03 ET110014.33
11:05 ET100014.26
11:07 ET130014.285
11:09 ET191214.24
11:14 ET10014.29
11:16 ET78514.265
11:25 ET20014.3739
11:32 ET80214.29
11:34 ET40014.32
11:38 ET31914.34
11:39 ET30014.4
11:41 ET10014.45
11:45 ET22414.455
11:48 ET30014.52
11:50 ET30014.46
11:52 ET20014.44
11:59 ET10014.465
12:03 ET82714.575
12:08 ET80314.57
12:10 ET10014.57
12:14 ET20014.54
12:15 ET10014.62
12:19 ET30014.62
12:21 ET10014.62
12:26 ET70014.62
12:30 ET80014.7
12:33 ET30014.65
12:42 ET10014.6
12:46 ET20014.59
12:50 ET10014.5
12:51 ET40014.47
12:57 ET220014.5
01:00 ET130614.6
01:02 ET30014.54
01:06 ET25014.42
01:08 ET10014.57
01:09 ET10014.5
01:13 ET40014.69
01:15 ET10014.67
01:18 ET50014.64
01:20 ET10014.625
01:24 ET10014.59
01:31 ET62814.55
01:33 ET40014.53
01:36 ET10014.54
01:38 ET40014.58
01:40 ET65014.5905
01:42 ET60014.61
01:44 ET40014.61
01:47 ET30014.49
01:49 ET50014.535
01:54 ET30014.59
01:56 ET40014.68
01:58 ET30014.65
02:00 ET60014.63
02:05 ET160014.739
02:07 ET10014.79
02:09 ET80014.805
02:12 ET105414.805
02:14 ET50014.85
02:16 ET116314.91
02:18 ET40014.96
02:20 ET60014.94
02:23 ET20014.93
02:25 ET10014.955
02:30 ET10014.955
02:34 ET10014.955
02:38 ET50014.95
02:41 ET171914.98
02:43 ET50014.98
02:52 ET116814.93
02:54 ET40014.87
02:56 ET719415.085
02:59 ET10015.11
03:01 ET91215.13
03:03 ET97315.14
03:06 ET30015.11
03:10 ET30015.16
03:12 ET188515.11
03:14 ET40015.13
03:15 ET20015.17
03:17 ET20015.16
03:19 ET100015.15
03:24 ET71915.15
03:26 ET20115.17
03:28 ET60215.17
03:30 ET90015.14
03:32 ET50015.22
03:33 ET154515.18
03:35 ET130015.2
03:37 ET50015.2
03:39 ET50015.28
03:42 ET100015.34
03:44 ET60015.34
03:46 ET130715.31
03:48 ET150015.32
03:50 ET455415.37
03:51 ET160015.24
03:53 ET90015.23
03:55 ET411315.24
03:57 ET427215.15
04:00 ET1501415.18
Data delayed at least 15 minutes.

Nov 16, 2021

8:00AM ET on Tuesday Nov 16, 2021 by GlobeNewswire

Nov 10, 2021

5:38PM ET on Wednesday Nov 10, 2021 by Thomson Reuters

4:22PM ET on Wednesday Nov 10, 2021 by MT Newswires
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesERAS
Erasca Inc
1.7B
0.0x
---
United StatesATAI
ATAI Life Sciences NV
1.8B
0.0x
---
United StatesADCT
ADC Therapeutics SA
1.7B
-6.8x
---
United StatesCLDX
Celldex Therapeutics Inc
1.7B
-21.4x
---
United StatesISEE
Iveric Bio Inc
1.6B
-13.3x
---
United StatesVERV
Verve Therapeutics Inc
1.6B
-13.9x
---
As of 2021-12-02

Company Information

Erasca, Inc is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company is engaged in oncology and RAS targeting to create therapies and combination regimens for the treatment of cancer. Its product candidates are ERAS-007 and ERAS-601, which together comprises its MAPKlamp. In addition, it also includes two discovery programs, ERAS-9 and ERAS-11, small molecule inhibitor programs targeting SOS1 and MYC, respectively. Its MAPKlamp is an approach targeting upstream and downstream nodes in the RAS/MAPK pathway designed to shut down, or clamp, the signaling of various oncogenic drivers, such as RTKs, NF1, RAS, RAF, and MEK alterations trapped in between any nodes involving this pathway. With its MAPKlamp approach, it induces tumor regression in RAS/MAPK pathway-driven cancers, while also blocking the escape routes that lead to tumor resistance.

Contact Information

Headquarters
10835 Road To The Cure, Suite 140SAN DIEGO, CA, United States 92121-1130
Phone
858-465-6511
Fax
302-636-5454

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Jonathan Lim
Chief Financial Officer
David Chacko
Director, Chair of Research and Development
Michael Varney
Senior Vice President - Finance
Brian Baker
Senior Vice President - Operations
Nik Chetwyn

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.7B
Revenue (TTM)
---
Shares Outstanding
121.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
---
Book Value
$0.90
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.